---
figid: PMC3733021__fimmu-04-00221-g001
figtitle: Schematic diagram of the ZFN, TALEN, and CRISPR/Cas9 genome editing tools
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
- Human immunodeficiency virus 1
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC3733021
filename: fimmu-04-00221-g001.jpg
figlink: /pmc/articles/PMC3733021/figure/F1/
number: F1
caption: (A) Schematic diagram of the ZFN, TALEN, and CRISPR/Cas9 genome editing tools.
  (B) Inhibition of T-cell activation by immune checkpoint receptors and downstream
  signaling proteins. Several co-inhibitory receptors (PD-1, BTLA, and LAIR-1) inhibit
  T-cell signaling by recruiting the SHP-1 and/or SHP-2 tyrosine phosphatases at proximity
  of the TCR signaling complex via ITIMs and ITSMs. This results in the dephosphorylation
  of proximal kinases downstream of TCR triggering. In addition PD-1 ligation was
  shown to induce increased expression of the Cbl-b E3 ubiquitin ligase, which targets
  signaling molecules for degradation. Activation of the CD200R leads to the recruitment
  of DOK2 and RasGAP to its intra-cellular domain, resulting in the inhibition of
  downstream MAP kinases. The adenosine receptor 2A and PGE2 receptors EP2 and EP4
  modulate T-cell activation through mobilization of the cAMP-PKAI-CSK pathway. CSK
  phosphorylates the inhibitory C-terminal tyrosine residue of Src kinases and negatively
  regulates TCR signaling. A2AR, adenosine A2a receptor; APC, antigen-presenting cell;
  BTLA-4, B- and T-lymphocyte attenuator; Cbl-b, casitas B-cell lymphoma; CTL, cytotoxic
  T-lymphocyte; DOK-1/2, docking protein 1/2; EP2/4, prostaglandin E receptor 2/4;
  Erk, extra-cellular signal regulated kinases; ITIM, immunoreceptor tyrosine-based
  inhibition motif; ITSM, immunoreceptor tyrosine-based switch motif; GPCR, G-protein
  coupled receptor; LAG-3, lymphocyte-activation gene 3; LAIR-1, leukocyte-associated
  immunoglobulin-like receptor 1; Lck, lymphocyte-specific protein tyrosine kinase;
  MHC1, major histocompatibility complex class 1; PD-1, programed death receptor 1;
  PD1-L1, programed death receptor 1-ligand 1; SHP-1, Src homology 2 domain containing
  protein tyrosine phosphatase; TCR, T-cell receptor; TIGIT, T-cell immunoreceptor
  with Ig and ITIM domains; TIM-3, T-cell immunoglobulin domain and mucin domain 3.
papertitle: 'Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer
  Adoptive Cellular Therapies.'
reftext: Angharad Lloyd, et al. Front Immunol. 2013;4:221.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9541649
figid_alias: PMC3733021__F1
figtype: Figure
redirect_from: /figures/PMC3733021__F1
ndex: 9c2e8ff2-dedc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3733021__fimmu-04-00221-g001.html
  '@type': Dataset
  description: (A) Schematic diagram of the ZFN, TALEN, and CRISPR/Cas9 genome editing
    tools. (B) Inhibition of T-cell activation by immune checkpoint receptors and
    downstream signaling proteins. Several co-inhibitory receptors (PD-1, BTLA, and
    LAIR-1) inhibit T-cell signaling by recruiting the SHP-1 and/or SHP-2 tyrosine
    phosphatases at proximity of the TCR signaling complex via ITIMs and ITSMs. This
    results in the dephosphorylation of proximal kinases downstream of TCR triggering.
    In addition PD-1 ligation was shown to induce increased expression of the Cbl-b
    E3 ubiquitin ligase, which targets signaling molecules for degradation. Activation
    of the CD200R leads to the recruitment of DOK2 and RasGAP to its intra-cellular
    domain, resulting in the inhibition of downstream MAP kinases. The adenosine receptor
    2A and PGE2 receptors EP2 and EP4 modulate T-cell activation through mobilization
    of the cAMP-PKAI-CSK pathway. CSK phosphorylates the inhibitory C-terminal tyrosine
    residue of Src kinases and negatively regulates TCR signaling. A2AR, adenosine
    A2a receptor; APC, antigen-presenting cell; BTLA-4, B- and T-lymphocyte attenuator;
    Cbl-b, casitas B-cell lymphoma; CTL, cytotoxic T-lymphocyte; DOK-1/2, docking
    protein 1/2; EP2/4, prostaglandin E receptor 2/4; Erk, extra-cellular signal regulated
    kinases; ITIM, immunoreceptor tyrosine-based inhibition motif; ITSM, immunoreceptor
    tyrosine-based switch motif; GPCR, G-protein coupled receptor; LAG-3, lymphocyte-activation
    gene 3; LAIR-1, leukocyte-associated immunoglobulin-like receptor 1; Lck, lymphocyte-specific
    protein tyrosine kinase; MHC1, major histocompatibility complex class 1; PD-1,
    programed death receptor 1; PD1-L1, programed death receptor 1-ligand 1; SHP-1,
    Src homology 2 domain containing protein tyrosine phosphatase; TCR, T-cell receptor;
    TIGIT, T-cell immunoreceptor with Ig and ITIM domains; TIM-3, T-cell immunoglobulin
    domain and mucin domain 3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Apc
  - Serpina5
  - Gpbar1
  - Trav6-3
  - Tim
  - Timeless
  - Tpi1
  - Tigit
  - Pdcd1
  - Btla
  - Lag3
  - Lair1
  - Cd200r1
  - Cd3e
  - Cd247
  - D9Mgc45e
  - Ptpn6
  - Sirpa
  - Nr0b2
  - Ptpn11
  - Dok1
  - Art4
  - Dok2
  - Csk
  - da
  - Tal
  - APC
  - PROC
  - SERPINA5
  - MPI
  - PMM2
  - TMEM11
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - CD8A
  - CD8B
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - TPI1
  - ARHGEF5
  - TIMELESS
  - HAVCR1
  - TIGIT
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - BTLA
  - LAG3
  - LAIR1
  - CD200R1
  - CD247
  - CD3D
  - CD3E
  - CD3G
  - ATP8A2
  - PTPN6
  - DOK1
  - ART4
  - DOK2
  - CSK
  - TALDO1
  - LRSAM1
  - apc
  - kita
  - ngfra
  - timeless
  - ighv1-2
  - ptpn6
  - ptpn11a
  - dok1b
  - dok2
  - pak2a
  - itpka
  - csk
  - taldo1
  - Apc2
  - Axn
  - Fs(3)Apc
  - pi
  - Pmi
  - Tm1
  - Oamb
  - zen
  - Tcr
  - tim
  - timeout
  - ATPsynbeta
  - Atpalpha
  - csw
  - costakink
  - fok
  - nAChRalpha2
  - Taldo
  - tal-2A
  - tal-AA
  - tal-3A
  - tal-1A
  - ctl
  - cutlet
  - adenosine
  - Phosphate
  - PGE2
---
